Manacquit, Jereck C.

HRN: 28-96-36  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2026
CEFTRIAXONE 1G (VIAL)
05/07/2026
05/14/2026
IV
2g
OD
Lacerated Wound And Abrasions
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines